Importance Evidence-based therapies to reduce atherosclerotic cardiovascular disease risk
in adults with type 2 diabetes are underused in clinical practice. Objective To assess the …

Importance Based on contemporary estimates in the US, evidence-based therapies for
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …

In summary, in a large contemporary US cohort of patients with diabetes mellitus and
ASCVD, few patients received comprehensive guideline–recommended medical therapies …

Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Background: The effect of multifaceted lifestyle interventions on clinically oriented outcomes
across a spectrum of metabolic risk factors and abnormal glucose is unclear. Purpose: To …

Objectives Poorly controlled type 2 diabetes mellitus (T2DM) is a major international health
problem. Our aim was to assess the effectiveness of healthcare interventions, specifically …

Objectives: This study evaluated data from 3 federally funded trials that focused on optimal
medical therapy to determine if formalized attempts at risk factor control within clinical trials …

OBJECTIVE To compare effects of combinations of standard and intensive treatment of
glycemia and either blood pressure (BP) or lipids in the Action to Control Cardiovascular …

Based on the results of the UK Pro-spective Diabetes Study (UKPDS),“... treatment of type 2
diabetes [should] include aggressive efforts to lower blood glucose levels as close to normal …

The American College of Cardiology (ACC) develops a wide range of policy documents to
provide members with guidance on clinical topics. Although Clinical Practice Guidelines …